USD 7.63 billion
Orthobiologics Market Size, Share, Growth Analysis, By Product(Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein), By Application(Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery), By End User(Hospitals, Orthopedic Clinics, & Ambulatory Care Centers), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2070 |
Region:
Global |
Published Date: September, 2024
Pages:
157
|Tables:
92
|Figures:
76
Orthobiologics Market Insights
Global Orthobiologics Market size was valued at USD 6.1 billion in 2022 and is poised to grow from USD 6.43 billion in 2023 to USD 9.87 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).
Orthobiologics comprises a wide range of products that improve healing of musculoskeletal conditions and injuries. This comprises stem cells, bone grafts, PRP (plasma-rich-platelet), and several other regenerative treatments. The global orthobiologics market is considerably impacted by factors like increasing developments and advances in regenerative medicine therapies, growing senior population, and growing incidences of orthopedic procedures. Nonetheless, a few restraints hampering the growth of the orthobiologics market include stringent approval processes, lack of standardization, and costly surgeries and treatments. Still, the market is anticipated to witness substantial growth over the estimated period owing to opportunities like expanding applications of orthobiologics, rising research and developments, and growing inclination towards personalized medicine.
US Orthobiologics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
5.4% CAGR
Global Orthobiologics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Orthobiologics Market Segmental Analysis
Global Orthobiologics Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate. Based on Application, the market is segmented into Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications. Based on End User, the market is segmented into Hospitals, Orthopedic Clinics, & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Orthobiologics Market Analysis by Product
Based on product, the orthobiologics market is categorized into viscosupplementation products, demineralized bone matrices, synthetic orthobiologics, bone morphogenic protein, allografts, and stem cell therapy. The viscosupplementation products segment held a notable share of the market in the previous years and is expected to lead over the forecast period as well owing to the increasing incidences of osteoarthritis, increasing demand and preference for non-surgical treatments, and well-established safety and efficacy. Osteoarthritis, especially in the knee, is more common than other conditions. This increases the need for reliable and effective treatment choices like viscosupplementation to enhance joint function and relieve pain. Healthcare professionals and patients are currently preferring painless treatments than surgical options, increasing the popularity of viscosupplementation for joint pain.
On the other hand, the stem cell therapy segment is projected to grow considerably over the forecast period owing to its regenerative potential, versatile application, and improvements in research. Stem cells hold exceptional ability to encourage tissue repair and regeneration, which increases their preference for treating diverse musculoskeletal issues. They are also used for broader range of applications like spinal disorders, osteoarthritis, tendon injuries, and more, which widens their popularity and potential. Moreover, current clinical trials and research are constantly authenticating stem cell’s safety and efficacy, thus strengthening confidence among patients and professionals.
Orthobiologics Market Analysis by End User
Based on end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers. The hospitals segment held a notable market share in the previous years and is expected to continue dominance over the forecast period as well owing to exhaustive care facilities, access to professionals, and availability of improved equipment and technologies. Hospitals offer numerous services, comprising advanced diagnostics, surgical intervention, and emergency care, which make them the most preferred settings for complicated orthopedic surgeries and treatments. These settings are well-equipped with technical experts and trained healthcare professionals that allow integrated treatments plans that contain orthobiologics.
On the other hand, the orthopedic clinics segment will hold a notable market share in the forthcoming years owing to expertise in musculoskeletal disorders, increasing demand for non-invasive procedures, and better convenience and accessibility. Orthopedic clinics emphasize the treatment and diagnostic of various musculoskeletal issues, which make these settings highly proficient in administering orthobiologics. Patients are actively preferring painless or minimally invasive treatment options and orthopedic clinics are well-developed and equipped with technologies to offer them to patients. Hence, easy accessibility and convenience boost the preference for these clinics, impacting the market.
Global Orthobiologics Market Size By End User
To get detailed analysis on other segments, Request For Free Sample Report
Orthobiologics Market Regional Insights
Geographically, North America dominated the market in 2023 and is expected to lead over the forecast period owing to the presence of improved healthcare infrastructure, growing cases of musculoskeletal issues, and strong research and growing number of research and developments. North America brags about its developed healthcare infrastructure with easy access to superior technologies and well-trained professionals. Regional growth is also impacted by the rising number of sports patients that report sports injuries and osteoarthritis issues. This majorly demands improved and innovative treatments. Furthermore, increasing amount of research and development fuels modernizations in orthobiologics, resulting in the emergence of novel therapies. The key players profiled in the region include Amgen Inc., Medtronic, Zimmer Biomet, Stryker Corporation, Amedica Corporation, Bone Therapeutics, and more.
Europe is the fastest-growing region in the global orthobiologics market due to strong research and innovation, regulatory support, and the growing aging population. Europe is the leading center for several universities and research institutes that emphasize orthobiologics and regenerative medicines, which drives developments and innovations. The region also holds supportive frameworks that streamline the selling and approval of novel products, thus impacting market growth. Furthermore, the growing senior population in Europe is majorly impacting the demand for orthopedic-associated surgeries and the need for more effective procedures.
Global Orthobiologics Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Orthobiologics Market Dynamics
Orthobiologics Market Driver
Improvements in Regenerative Medicine
- Modernized technologies and R&D are majorly impacting the growth of the orthobiologics market, innovations in PRP, stem cell therapies, and several other associated techniques are increasing the accessibility, availability, and efficacy of orthobiologics, thus impacting the market growth. Moreover, current research and trials are resulting in the emergence of novel treatment modalities and products. This improves the healing process and overall recovery.
Increasing Sports Participation and Associated Injuries
- The growing trend towards leading active lives and emphasis on preventive health measures is significantly driving the market growth. There is a rising focus on sports participation and fitness, which increases the sports-caused injuries, thus demanding quick healing treatments options. Individuals and athletes are actively preferring orthobiologics for preventing injuries and better recovery.
Restraints
Low Clinical Evidence
- The growing need for extensive research and variable outcomes is majorly hindering the growth of the market. Despite there are several promises through deep research and advancements, lack of exhaustive clinical research aiding the efficiency of several some orthobiologics therapies may restrict their acceptance and use by medical professionals. Moreover, inconsistent outcomes in studies may result in scepticism about the efficacy of specific products, affecting adoption.
Fluctuation in Patient Responses
- Variations in health conditions and patient biology may result in changeable outcomes associated with orthobiologics, which may further create difficulties in treatment. This may adversely affect market growth. Challenges in personalization are also negatively impacting market growth. With the growing personalization medicine trend, personalization is still challenging owing to the intricacy of separate patient profiles.
Request Free Customization of this report to help us to meet your business objectives.
Orthobiologics Market Competitive Landscape
The global orthobiologics market is a competitive and speedy evolving market driven by the prominent market players. The leading companies like Johnson & Johnson, Medtronic, and Stryker are holding major market share with a broader range of products like stem cells and several growth factors. There is an increasing emphasis on obedience with stringent regulatory norms that affect market entry and timelines of product development for simplified approvals. Speedy advances in technology like surgeries, strategic collaborations, and heavy investments and expenditures on R&D define the competitive landscape.
Orthobiologics Market Top Player's Company Profiles
- Medtronic plc
- Stryker Corporation
- Globus Medical, Inc.
- Orthofix International N.V.
- RTI Surgical, Inc.
- Kuros Biosciences Ltd.
- Bioventus LLC
- Nuvasive, Inc.
- Seaspine Holdings Corporation
- Arthrex, Inc.
- Xtant Medical Holdings, Inc.
- Sanofi S.A.
- Smith & Nephew plc
- Integra LifeSciences Holdings Corporation
- Anika Therapeutics, Inc.
- Alphatec Spine, Inc.
- Orthocell Ltd.
- MiMedx Group, Inc.
- Orthofix Medical Inc.
- Bone Therapeutics SA
Orthobiologics Market Recent Developments
- In September 2024, Stryker introduced the addition of two novel products to its product line of Foot & Ankle. Ankle Truss System™ (ATS) and Osteotomy Truss System™ (OTS) lately acquired by 4WEB Medical. Stryker will present both the products at the AOFAS Annual Meeting in Canada.
- In September 2024, Orthofix Medical Incorporation announced the introduction of fresh data aiding the use of the company’s branded (PEMF) Pulsed Electromagnetic Field simulation to accelerate fusion rates as an assistant to lumbar spine fusion procedure.
- In November 2023, Smith+Nephew announced that it signed a contract to acquire CartiHeal. This acquisition supports Smith+Nephew’s strategy to invest behind its successful Sports Medicine Business. Also, the purchase will accompany their current knee repair product line with commercial specialization in high-growth biologics.
Orthobiologics Key Market Trends
- Growing Prominence of PRP Treatment: Platelet-Rich Plasma or PRP is gaining significant prominence for its application in joint pain, soft tissue injuries, and post-surgical recovery. Hence, it is majorly gaining popularity in regenerative applications. Moreover, the growing number of efforts and initiatives are being imposed to standardize preparation of PRP and administration policies to improve reproducibility and efficacy.
- Integration of Biologics in Less-Invasive Surgeries: The incorporation of orthobiologics in less-invasive surgeries is majorly aiding in improved heal times and better patient results. This enhances patient recovery and improves patient experience. Moreover, growing advances in surgical techniques and imaging methodologies are streamlining more accurate application of orthobiologics during procedures. Hence, a greater number of innovations will notably impact market growth.
Orthobiologics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the Orthobiologics market is considerably progressing due to the expanding applications in numerous sectors, growing adoption of preventive healthcare, and growth of home-based tests. However, the market is hampered by the changing regulations, the growing competition from alternate diagnostic methods, and legal and ethical considerations. North America is anticipated to lead the market owing to rising incidences of chronic and infectious diseases, high research and development investment, and favorable regulatory policies. Nonetheless, a few opportunities for the growth of the Orthobiologics market include the integration of telemedicine, growing sustainability initiatives, and the development of combination tests.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 6.1 billion |
| Market size value in 2031 | USD 9.87 billion |
| Growth Rate | 5.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Orthobiologics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Orthobiologics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Orthobiologics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Orthobiologics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Orthobiologics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Orthobiologics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
